{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T03:15:56Z","timestamp":1785640556177,"version":"3.56.0"},"reference-count":47,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.3201\/eid2501.180111","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T13:46:49Z","timestamp":1543499209000},"page":"52-62","source":"Crossref","is-referenced-by-count":23,"title":["Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and <i>Clostridioides difficile<\/i> Infection in Secondary Healthcare Settings"],"prefix":"10.3201","volume":"25","author":[{"given":"Geraldine Mary","family":"Conlon-Bingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoon","family":"Aldeyab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Patricia","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Farren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McElnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2501.180111-201812142037-R1","doi-asserted-by":"publisher","first-page":"i87","DOI":"10.1093\/jac\/dkm185","article-title":"Specialist Advisory Committee on Antimicrobial Resistance Antimicrobial Framework.","volume":"60","author":"Specialist Advisory Committee on Antimicrobial Resistance (SACAR)","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/jac\/dkv492","article-title":"Implementation of antimicrobial stewardship interventions recommended by national toolkits in primary and secondary healthcare sectors in England: TARGET and Start Smart Then Focus.","volume":"71","author":"Ashiru-Oredope","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R3","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1093\/jac\/dkt363","article-title":"Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR).","volume":"68","author":"Ashiru-Oredope","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1086\/658333","article-title":"Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.","volume":"32","author":"Aldeyab","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2501.180111-201812142037-R5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1017\/S0950268813001374","article-title":"Impact of an enhanced antibiotic stewardship on reducing methicillin-resistant Staphylococcus aureus in primary and secondary healthcare settings.","volume":"142","author":"Aldeyab","year":"2014","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2501.180111-201812142037-R6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijantimicag.2014.11.006","article-title":"Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital.","volume":"45","author":"Cook","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2501.180111-201812142037-R7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijantimicag.2014.01.011","article-title":"Of stewardship, motherhood and apple pie.","volume":"43","author":"Livermore","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2501.180111-201812142037-R8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1749-6632.2010.05867.x","article-title":"Antibiotic heterogeneity: from concept to practice.","volume":"1213","author":"Bal","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.3201\/eid2501.180111-201812142037-R9","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S0924-8579(10)70005-4","article-title":"Antibiotic heterogeneity.","volume":"36","author":"Masterton","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2501.180111-201812142037-R10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/01.CCM.0000195010.63855.45","article-title":"Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units.","volume":"34","author":"Mart\u00ednez","year":"2006","journal-title":"Crit Care Med"},{"key":"key-10.3201\/eid2501.180111-201812142037-R11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1164\/ajrccm.162.3.9905050","article-title":"Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.","volume":"162","author":"Gruson","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid2501.180111-201812142037-R12","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1097\/01.CCM.0000069729.06687.DE","article-title":"Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.","volume":"31","author":"Gruson","year":"2003","journal-title":"Crit Care Med"},{"key":"key-10.3201\/eid2501.180111-201812142037-R13","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/j.jss.2011.12.014","article-title":"A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.","volume":"176","author":"Sarraf-Yazdi","year":"2012","journal-title":"J Surg Res"},{"key":"key-10.3201\/eid2501.180111-201812142037-R14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1542\/peds.110.4.707","article-title":"The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit.","volume":"110","author":"Toltzis","year":"2002","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2501.180111-201812142037-R15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/jac\/dkl097","article-title":"Impact of diversity of antibiotic use on the development of antimicrobial resistance.","volume":"57","author":"Sandiumenge","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1378\/chest.11-0462","article-title":"Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE Organisms.","volume":"140","author":"Sandiumenge","year":"2011","journal-title":"Chest"},{"key":"key-10.3201\/eid2501.180111-201812142037-R17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s00268-005-0781-7","article-title":"Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward.","volume":"30","author":"Takesue","year":"2006","journal-title":"World J Surg"},{"key":"key-10.3201\/eid2501.180111-201812142037-R18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.bmt.1705704","article-title":"Antibiotic cycling to decrease bacterial antibiotic resistance: a 5-year experience on a bone marrow transplant unit.","volume":"40","author":"Cadena","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"key-10.3201\/eid2501.180111-201812142037-R19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00134-009-1714-y","article-title":"Effects of reducing beta-lactam pressure on intestinal colonisation of antibiotic resistant gram-negative bacteria.","volume":"36","author":"Nijssen","year":"2010","journal-title":"J Intensive Care Med"},{"key":"key-10.3201\/eid2501.180111-201812142037-R20","doi-asserted-by":"publisher","first-page":"e38719","DOI":"10.1371\/journal.pone.0038719","article-title":"The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.","volume":"7","author":"Ginn","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2501.180111-201812142037-R21","doi-asserted-by":"publisher","first-page":"e54190","DOI":"10.1371\/journal.pone.0054190","article-title":"Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.","volume":"8","author":"Chong","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2501.180111-201812142037-R22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1086\/321807","article-title":"Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit.","volume":"33","author":"Puzniak","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2501.180111-201812142037-R23","doi-asserted-by":"publisher","first-page":"e1004225","DOI":"10.1371\/journal.ppat.1004225","article-title":"Cycling empirical antibiotic therapy in hospitals: meta-analysis and models.","volume":"10","author":"Abel zur Wiesch","year":"2014","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2501.180111-201812142037-R24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1086\/591741","article-title":"Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA\/HICPAC Position paper.","volume":"29","author":"Cohen","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2501.180111-201812142037-R25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1473-3099(07)70082-8","article-title":"The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.","volume":"7","author":"Stone","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2501.180111-201812142037-R26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jac\/dkn198","article-title":"Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.","volume":"62","author":"Aldeyab","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1469-0691.2009.03098.x","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).","volume":"15","author":"Crobach","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2501.180111-201812142037-R28","unstructured":"WHO Collaborating Center for Drug Statistics Methodology. Guidelines for ATC classifications and DDDs assignment [cited 2015 Apr 4]. http:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"key-10.3201\/eid2501.180111-201812142037-R29","doi-asserted-by":"publisher","first-page":"e3005","DOI":"10.1136\/bmj.e3005","article-title":"Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study.","volume":"344","author":"Stone","year":"2012","journal-title":"BMJ"},{"key":"key-10.3201\/eid2501.180111-201812142037-R30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key-10.3201\/eid2501.180111-201812142037-R31","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidelines for the detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. Sweden. 2013 [cited 2016 Aug 19]. http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Resistance_mechanisms\/EUCAST_detection_of_resistance_mechanisms_v1.0_20131211.pdf"},{"key":"key-10.3201\/eid2501.180111-201812142037-R32","unstructured":"Cochrane Effective Practice and Organisation of Care Group. Interrupted time series (ITS) analyses-SPSS time series analysis.2013 [cited 2016 Aug 18]. https:\/\/epoc.cochrane.org\/sites\/epoc.cochrane.org\/files\/uploads\/21%20Interrupted%20time%20series%20analyses%202013%2008%2012_1.pdf"},{"key":"key-10.3201\/eid2501.180111-201812142037-R33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijantimicag.2004.04.011","article-title":"The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.","volume":"24","author":"Tsukayama","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.3201\/eid2501.180111-201812142037-R34","doi-asserted-by":"publisher","first-page":"e53674","DOI":"10.1371\/journal.pone.0053674","article-title":"MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death.","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2501.180111-201812142037-R35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.amjmed.2007.07.034","article-title":"The risk of infection after nasal colonization with Staphylococcus aureus.","volume":"121","author":"Safdar","year":"2008","journal-title":"Am J Med"},{"key":"key-10.3201\/eid2501.180111-201812142037-R36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1017\/ice.2015.190","article-title":"Risk of MRSA infection in patients with intermittent versus persistent MRSA nares colonization.","volume":"36","author":"Vigil","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.3201\/eid2501.180111-201812142037-R37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cid\/ciu236","article-title":"on behalf of the Antibiotic Use and Staphylococcus aureus Resistance to Antibiotics (ASAR) Study Group. Fluoroquinolone use is a risk factor for methicillin resistant Stapylococcus aureus acquisition in long-term care facilities: a nested case\u2013control study.","volume":"39","author":"Couderc","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2501.180111-201812142037-R38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhin.2012.07.013","article-title":"Temporal effects of infection control practices and the use of antibiotics on the incidence of MRSA.","volume":"82","author":"Bertrand","year":"2012","journal-title":"J Hosp Infect"},{"key":"key-10.3201\/eid2501.180111-201812142037-R39","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/jac\/dkr253","article-title":"Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.","volume":"66","author":"Talpaert","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dkn199","article-title":"Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile.","volume":"62","author":"Vernaz","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2125.2011.04161.x","article-title":"The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings.","volume":"74","author":"Aldeyab","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"key-10.3201\/eid2501.180111-201812142037-R42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/jac\/dkl102","article-title":"Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-\u03b2-lactamase-producing Escherichia coli with amoxicillin\/clavulanate: case report and characterization of the isolate.","volume":"57","author":"Lagac\u00e9-Wiens","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R43","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1001\/archinte.168.17.1897","article-title":"Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.","volume":"168","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid2501.180111-201812142037-R44","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis.","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid2501.180111-201812142037-R45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"The extended spectrum beta lactamases group. \u03b2-lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteraemia due to extended spectrum \u03b2-lactamase producing Escherichia coli: a post hoc analysis of prospective cohorts.","volume":"54","author":"Rodriguez Bano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2501.180111-201812142037-R46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1473-3099(14)70950-8","article-title":"\u03b2-lactam and \u03b2-lactamase inhibitor combinations in the treatment of extended-spectrum \u03b2-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?","volume":"15","author":"Harris","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2501.180111-201812142037-R47","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/jac\/dkl343","article-title":"Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis.","volume":"58","author":"Muller","year":"2006","journal-title":"J Antimicrob Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/1\/18-0111_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:25:29Z","timestamp":1732987529000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/1\/18-0111_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2501.180111","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}